Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial

Journal of Affective Disorders

Volumn 204, Issue , 2016, Pages 1-8

  Jafarinia, Morteza ^a   Afarideh, Mohsen ^b   Tafakhori, Abbas ^c   Arbabi, Mohammad ^b   Ghajar, Alireza ^b   Noorbala, Ahmad Ali ^a   Saravi, Maryam Alamdar ^a   Agah, Elmira ^c   Akhondzadeh, Shahin ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Depression; Diclofenac; Oral ketamine; Randomized controlled trial

Indexed keywords

DICLOFENAC; KETAMINE; ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; ADULT; ANXIETY; ARTICLE; BLURRED VISION; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; LOSS OF APPETITE; MALE; MONOTHERAPY; NERVOUSNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RESTLESSNESS; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; COMPARATIVE STUDY; DRUG ADMINISTRATION; FOLLOW UP; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PSYCHOLOGY;

ADMINISTRATION, ORAL; ADULT; ANTIDEPRESSIVE AGENTS; CHRONIC PAIN; DEPRESSION; DICLOFENAC; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KETAMINE; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84975144373     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.05.076     Document Type: Article

References (33)

1. Aan Het Rot, M. Zarate, C.A. Charney Jr., and D.S. Mathew, S.J Ketamine for depression: where do we go from here? Biol. Psychiatry 72 7 2012 537 547
2. M.J. Bair, R.L. Robinson, W. Katon, and K. Kroenke Depression and pain comorbidity: a literature review Arch. Intern. Med. 163 20 2003 2433 2445
3. I. Bjelland, A.A. Dahl, T.T. Haug, and D. Neckelmann The validity of the Hospital Anxiety and Depression Scale: an updated literature review J. Psychosom. Res. 52 2 2002 69 77
4. H. Caci, F.J. Baylé, V. Mattei, C. Dossios, P. Robert, and P. Boyer How does the Hospital and Anxiety and Depression Scale measure anxiety and depression in healthy subjects? Psychiatry Res. 118 1 2003 89 99
5. J.A., Clements, W.S. Nimmo, and I.S. Grant Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans J. Pharm. Sci. 71 5 1982 539 542
6. J.W. Dotson, D.L. Ackerman, and L.J. West Ketamine abuse J. Drug Issues 25 4 1995 751 757
7. R.S. Duman, and G.K. Aghajanian Synaptic dysfunction in depression: potential therapeutic targets Science 338 6103 2012 68 72
8. M. Dunbar, G. Ford, K. Hunt, and G. Der A confirmatory factor analysis of the Hospital Anxiety and Depression Scale: comparing empirically and theoretically derived structures Br. J. Clin. Psychol. 39 1 2000 79 94
9. N.P. Emptage, R. Sturm, and R.L. Robinson Depression and comorbid pain as predictors of disability, employment, insurance status, and health care costs Psychiatr. Serv. 56 4 2014 468 474
10. B. Gharaei, A.H. Mehryar, and M. Mehrabi Attribution style in patients with anxiety and depression comorbidity Iran. J. Psychiatry Clin. Psychol. 5 20 2000 437 442
11. C. Haile, J.W. Murrough, D.V. Iosifescu, L.C. Chang, R.K. Al Jurdi, A. Foulkes, S. Iqbal, J.J. Mahoney 3rd, R. De La Garza 2nd, D.S. Charney, T.F. Newton, and S.J. Mathew Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression Int. J. Neuropsychopharmacol. 17 2 2014 331 336
12. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1 1960 56
13. R.C. Hatton, J. Patel, M.W. Low, and O. Ganesh Use of oral ketamine by academic hospitals in the US Ann. Pharmacother. 47 4 2013 591 592
14. U. Heresco-Levy, G. Gelfin, B. Bloch, R. Levin, S. Edelman, D.C. Javitt, and I. Kremer A randomized add-on trial of high-dose d-cycloserine for treatment-resistant depression Int. J. Neuropsychopharmacol. 16 3 2013 501 506
15. M. Herrero, J. Blanch, J.M. Peri, J. De Pablo, L. Pintor, and A. Bulbena A validation study of the Hospital Anxiety and Depression Scale (HADS) in a Spanish population Gen. Hosp. Psychiatry 25 4 2003 277 283
16. C. Herrmann International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results J. Psychosom. Res. 42 1 1997 17 41
17. C.-C. Huang, I.H. Wei, C.L. Huang, K.T. Chen, M.H. Tsai, P. Tsai, R. Tun, K.H. Huang, Y.C. Chang, H.Y. Lane, and G.E. Tsai Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression Biol. Psychiatry 74 10 2013 734 741
18. S.A. Irwin, A. Iglewicz, R.A. Nelesen, J.Y. Lo, C.H. Carr, S.D. Romero, and L.S. Lloyd Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial J. Palliat. Med 16 8 2013 958 965
19. M. Johnston, B. Pollard, and P. Hennessey Construct validation of the hospital anxiety and depression scale with clinical populations J. Psychosom. Res. 48 6 2000 579 584
20. D. Khajavi, M. Farokhnia, A. Modabbernia, M. Ashrafi, S.H. Abbasi, M. Tabrizi, and S. Akhondzadeh Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study J. Clin. Psychiatry 73 11 2012 1428 1433
21. K.A. Lapidus, C.F. Levitch, A.M. Perez, J.W. Brallier, M.K. Parides, Soleimani, A. Feder, D.V. Iosifescu, D.S. Charney, and J.W. Murrough A randomized controlled trial of intranasal ketamine in major depressive disorder Biol. Psychiatry 76 12 2014 970 976
22. D.R. Lara, L.W. Bisol, and L.R. Munari Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression Int. J. Neuropsychopharmacol. 16 9 2013 2111 2117
23. S.J. Linton, and S. Bergbom Understanding the link between depression and pain Scand. J. Pain. 2 2 2011 47 54
24. D. Macklin Phlebitis: a painful complication of peripheral IV catheterization that may be prevented Am. J. Nurs. 103 2 2003 55 60
25. A. McGirr, M.T. Berlim, D.J. Bond, M.P. Fleck, L.N. Yatham, and R.W. Lam A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes Psychol. Med. 45 04 2015 693 704
26. M. Naughton, G. Clarke, O.F. O'Leary, J.F. Cryan, and T.G. Dinan A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action J. Affect Disord. 156 2014 24 35
27. C. Otte, S. Zhao, and M.A. Whooley Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the heart and soul study J. Clin. Psychiatry 73 5 2012 610 615
28. N.A. Poole, and J.F. Morgan Validity and reliability of the Hospital Anxiety and Depression Scale in a hypertrophic cardiomyopathy clinic: the HADS in a cardiomyopathy population Gen. Hosp. Psychiatry 28 1 2006 55 58
29. N. Samaras, F.R. Herrmann, D. Samaras, P.O. Lang, A. Canuto, A. Forster, H. Hilleret, and G. Gold The Hospital Anxiety and Depression Scale: low sensitivity for depression screening in demented and non-demented hospitalized elderly Int. Psychogeriatr. 25 01 2013 82 87
30. Y. Yanagihara, M. Ohtani, M. Matsumoto, S. Kariya, K. Uchino, T. Hiraishi, N. Ashizawa, T. Aoyama, Y. Yamamura, and T. Iga Preparation of ketamine tablets for treatment of patients with neuropathic pain Yakugaku zasshi: J. Pharm. Soc. Jpn. 119 12 1999 980 987
31. C. Yang, M. Han, J.C. Zhang, Q. Ren, and K. Hashimoto Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine Psychiatry Res. 239 2016 281 283
32. C.A. Zarate, J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, D.A. Luckenbaugh, D.S. Charney, and H.K. Manji A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression Arch. Gen. Psychiatry 63 8 2006 856 864
33. A.S. Zigmond, and R.P. Snaith The hospital anxiety and depression scale Acta Psychiatr Scand. 67 6 1993 361 370